Anthony E Sisk

Title(s)Hs Associate Clinical Professor, Pathology and Laboratory Medicine
SchoolMedicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Performance of MR fusion biopsy, systematic biopsy and combined biopsy on prostate cancer detection rate in 1229 patients stratified by PI-RADSv2 score on 3T multi-parametric MRI. Abdom Radiol (NY). 2025 Jan 18. Riskin-Jones HH, Raman AG, Kulkarni R, Arnold CW, Sisk A, Felker E, Lu DS, Marks LS, Raman SS. PMID: 39825007.
      View in: PubMed   Mentions:    Fields:    
    2. Quantitative 3-T Multiparametric MRI Parameters as Predictors of Aggressive Prostate Cancer. Radiol Imaging Cancer. 2025 Jan; 7(1):e240011. Kim DHS, Sonni I, Grogan T, Sisk A, Murthy V, Hsu W, Sung K, Lu DS, Reiter RE, Raman SS. PMID: 39750113.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot Study. J Nucl Med. 2024 Dec 03; 65(12):1952-1958. Huang RR, Zuo C, Mona CE, Holzgreve A, Morrissey C, Nelson PS, Brady L, True L, Sisk A, Czernin J, Calais J, Ye H. PMID: 39477498; PMCID: PMC11619584.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI. J Nucl Med. 2024 Dec 03; 65(12):1923-1931. Sonni I, Weiner AB, Doddipalli S, Deol M, Ban D, Kim HO, Grogan T, Ahuja P, Barroso N, Zong Y, Soin P, Sisk A, Czernin J, Hsu W, Calais J, Reiter RE, Raman SS. PMID: 39477501.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Digital Volumetric Biopsy Cores Improve Gleason Grading of Prostate Cancer Using Deep Learning. ArXiv. 2024 Sep 12. Redekop E, Pleasure M, Wang Z, Sisk A, Zong Y, Flores K, Speier W, Arnold CW. PMID: 39314499; PMCID: PMC11419188.
      View in: PubMed   Mentions:
    6. Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm. BJUI Compass. 2024 Oct; 5(10):986-997. Priester A, Mota SM, Grunden KP, Shubert J, Richardson S, Sisk A, Felker ER, Sayre J, Marks LS, Natarajan S, Brisbane WG. PMID: 39416757; PMCID: PMC11479810.
      View in: PubMed   Mentions: 1  
    7. Evaluation of prostate cancer detection using micro-ultrasound versus MRI through co-registration to whole-mount pathology. Sci Rep. 2024 08 14; 14(1):18910. Pensa J, Brisbane W, Kinnaird A, Kuppermann D, Hughes G, Ushko D, Priester A, Gonzalez S, Reiter R, Chin A, Sisk A, Felker E, Marks L, Geoghegan R. PMID: 39143293; PMCID: PMC11324719.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. ALK Inhibition With Alectinib for Refractory Metastatic Renal Cell Carcinoma With ALK Rearrangement: A Rare Case Report and Literature Review. JCO Precis Oncol. 2024 Jun; 8:e2400154. Kathuria-Prakash N, Lopez LP, Raman S, Ye H, Anaokar J, Sisk A, Pantuck AJ, Drakaki A. PMID: 38885453.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Investigating MRI-Associated Biological Aspects of Racial Disparities in Prostate Cancer for African American and White Men. J Magn Reson Imaging. 2025 Jan; 61(1):121-131. Zabihollahy F, Miao Q, Naim S, Sonni I, Vangala S, Kim H, Hsu W, Sisk A, Reiter R, Raman SS, Sung K. PMID: 38751322; PMCID: PMC11564416.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Trichomonas vaginalis adherence phenotypes and extracellular vesicles impact parasite survival in a novel in vivo model of pathogenesis. PLoS Negl Trop Dis. 2023 Oct; 17(10):e0011693. Molgora BM, Mukherjee SK, Baumel-Alterzon S, Santiago FM, Muratore KA, Sisk AE, Mercer F, Johnson PJ. PMID: 37871037; PMCID: PMC10621976.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    11. Adrenal schwannoma can be FDG-Avid on PET/CT: case report and review of historic institutional pathology. Diagn Pathol. 2023 Oct 13; 18(1):112. Fackelmayer OJ, Rodriguez ED, Sisk AE, Livhits MJ. PMID: 37833805; PMCID: PMC10576362.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. [68Ga]Ga-FAPI-46 PET for Visualization of Postinfarction Renal Fibrosis. J Nucl Med. 2023 10; 64(10):1660-1661. Unterrainer LM, Sisk AE, Czernin J, Shuch BM, Calais J, Hotta M. PMID: 37321822.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. Focal therapy of prostate cancer: Assessment with prostate-specific membrane antigen (PSMA) imaging. Urol Case Rep. 2023 Sep; 50:102461. Topoozian M, Calais J, Felker E, Sisk A, Gonzalez S, Lee SJ, Marks LS. PMID: 37358989; PMCID: PMC10285561.
      View in: PubMed   Mentions: 1  
    14. Racial Disparities in Quantitative MRI for African American and White Men with Prostate Cancer. Res Sq. 2023 Feb 15. Zabihollahy F, Miao Q, Sonni I, Vangala S, Kim H, Hsu W, Sisk A, Reiter R, Raman S, Sung K. PMID: 36824946; PMCID: PMC9949266.
      View in: PubMed   Mentions:
    15. Cryotherapy for partial gland ablation of prostate cancer: Oncologic and safety outcomes. Cancer Med. 2023 04; 12(8):9351-9362. Aker MN, Brisbane WG, Kwan L, Gonzalez S, Priester AM, Kinnaird A, Delfin MK, Felker E, Sisk AE, Kuppermann D, Marks LS. PMID: 36775929; PMCID: PMC10166973.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    16. Utility of Magnetic Resonance Imaging for Localizing Prostate Cancer Near the Urethra in Men Who Are Candidates for Focal Gland Ablation. J Urol. 2023 05; 209(5):911-917. Patel N, Hughes A, Zhang JH, Brisbane W, Rastegarpour A, Afsahir S, Kwan L, Nguyen AV, Sisk A, Raman S, Reiter R. PMID: 36753630.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena. J Hematol Oncol. 2022 05 03; 15(1):48. Khoo A, Liu LY, Sadun TY, Salmasi A, Pooli A, Felker E, Houlahan KE, Ignatchenko V, Raman SS, Sisk AE, Reiter RE, Boutros PC, Kislinger T. PMID: 35505417; PMCID: PMC9066728.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    18. PathAL: An Active Learning Framework for Histopathology Image Analysis. IEEE Trans Med Imaging. 2022 05; 41(5):1176-1187. Li W, Li J, Wang Z, Polson J, Sisk AE, Sajed DP, Speier W, Arnold CW. PMID: 34898432; PMCID: PMC9199991.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    19. Acute interstitial nephritis observed with three different triggering agents. Clin Case Rep. 2022 Mar; 10(3):e05432. Nobakht N, Hanna RM, Kamgar M, Sinclair J, Simon L, Emami S, Sisk A, Rastogi A. PMID: 35340649; PMCID: PMC8933633.
      View in: PubMed   Mentions: 1  
    20. A prostate cancer risk calculator: Use of clinical and magnetic resonance imaging data to predict biopsy outcome in North American men. Can Urol Assoc J. 2022 Mar; 16(3):E161-E166. Kinnaird A, Brisbane W, Kwan L, Priester A, Chuang R, Barsa DE, Delfin M, Sisk A, Margolis D, Felker E, Hu J, Marks LS. PMID: 34672937; PMCID: PMC8923894.
      View in: PubMed   Mentions: 6  
    21. Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional Sampling. Eur Urol. 2022 09; 82(3):303-310. Brisbane WG, Priester AM, Ballon J, Kwan L, Delfin MK, Felker ER, Sisk AE, Hu JC, Marks LS. PMID: 35115177.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimals
    22. Magnetic Resonance Imaging-Guided Biopsy in Active Surveillance of Prostate Cancer. J Urol. 2022 04; 207(4):823-831. Kinnaird A, Yerram NK, O'Connor L, Brisbane W, Sharma V, Chuang R, Jayadevan R, Ahdoot M, Daneshvar M, Priester A, Delfin M, Tran E, Barsa DE, Sisk A, Reiter RE, Felker E, Raman S, Kwan L, Choyke PL, Merino MJ, Wood BJ, Turkbey B, Pinto PA, Marks LS. PMID: 34854746; PMCID: PMC10506469.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. A System for Co-Registration of High-Resolution Ultrasound, Magnetic Resonance Imaging, and Whole-Mount Pathology for Prostate Cancer. Annu Int Conf IEEE Eng Med Biol Soc. 2021 11; 2021:3890-3893. Pensa J, Brisbane W, Priester A, Sisk A, Marks L, Geoghegan R. PMID: 34892082.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial. J Nucl Med. 2022 06; 63(6):847-854. Sonni I, Felker ER, Lenis AT, Sisk AE, Bahri S, Allen-Auerbach M, Armstrong WR, Suvannarerg V, Tubtawee T, Grogan T, Elashoff D, Eiber M, Raman SS, Czernin J, Reiter RE, Calais J. PMID: 34649942; PMCID: PMC9157724.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    25. Deep learning-based transformation of H&E stained tissues into special stains. Nat Commun. 2021 08 12; 12(1):4884. de Haan K, Zhang Y, Zuckerman JE, Liu T, Sisk AE, Diaz MFP, Jen KY, Nobori A, Liou S, Zhang S, Riahi R, Rivenson Y, Wallace WD, Ozcan A. PMID: 34385460; PMCID: PMC8361203.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    26. Regulation of telomere homeostasis and genomic stability in cancer by N6-adenosine methylation (m6A). Sci Adv. 2021 Jul; 7(31). Lee JH, Hong J, Zhang Z, de la Peña Avalos B, Proietti CJ, Deamicis AR, Guzmán G P, Lam HM, Garcia J, Roudier MP, Sisk AE, De La Rosa R, Vu K, Yang M, Liao Y, Scheirer J, Pechacek D, Yadav P, Rao MK, Zheng S, Johnson-Pais TL, Leach RJ, Elizalde PV, Dray E, Xu K. PMID: 34321211; PMCID: PMC8318370.
      View in: PubMed   Mentions: 16     Fields:    
    27. Kidney allograft infarction associated with transplant renal artery stenosis in a COVID-19 kidney transplant recipient. Clin Nephrol Case Stud. 2021; 9:93-104. Tantisattamo E, Dafoe DC, Ferrey AJ, Ichii H, Lee RA, Zuckerman JE, Sisk AEJ, Farzaneh T, Guccione J, Kabutey NK, Kalantar-Zadeh K, Reddy UG. PMID: 34476173; PMCID: PMC8387732.
      View in: PubMed   Mentions: 4  
    28. Intestinal mucormycosis initially identified by next-generation sequencing of cell-free DNA. Transpl Infect Dis. 2021 Aug; 23(4):e13656. Martin-Blais R, Pathak S, Fitzwater S, Dawson DW, Sisk AE, Farmer DG, Venick R, Yeganeh N. PMID: 34176206.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Papillary renal cell carcinoma: Review. Urol Oncol. 2021 06; 39(6):327-337. Mendhiratta N, Muraki P, Sisk AE, Shuch B. PMID: 34034966.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    30. Optimizing Spatial Biopsy Sampling for the Detection of Prostate Cancer. J Urol. 2021 09; 206(3):595-603. Raman AG, Sarma KV, Raman SS, Priester AM, Mirak SA, Riskin-Jones HH, Dhinagar N, Speier W, Felker E, Sisk AE, Lu D, Kinnaird A, Reiter RE, Marks LS, Arnold CW. PMID: 33908801; PMCID: PMC8903239.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    31. A multi-resolution model for histopathology image classification and localization with multiple instance learning. Comput Biol Med. 2021 04; 131:104253. Li J, Li W, Sisk A, Ye H, Wallace WD, Speier W, Arnold CW. PMID: 33601084; PMCID: PMC7984430.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    32. Acute interstitial nephritis and PR3-ANCA following reintroduction of pembrolizumab: a case report. Immunotherapy. 2021 03; 13(4):283-288. Mulroy M, Ghafouri S, Sisk A, Ribas A, Goshtaseb R, Cherry G, Shen J. PMID: 33397120.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    33. Predicting Pathological Tumor Size in Prostate Cancer Based on Multiparametric Prostate Magnetic Resonance Imaging and Preoperative Findings. J Urol. 2021 02; 205(2):444-451. Pooli A, Johnson DC, Shirk J, Markovic D, Sadun TY, Sisk AE, Mohammadian Bajgiran A, Afshari Mirak S, Felker ER, Hughes AK, Raman SS, Reiter RE. PMID: 33026934.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    34. Association of tumor grade, enhancement on multiphasic CT and microvessel density in patients with clear cell renal cell carcinoma. Abdom Radiol (NY). 2020 10; 45(10):3184-3192. Coy H, Young JR, Pantuck AJ, Douek ML, Sisk A, Magyar C, Brown MS, Sayre J, Raman SS. PMID: 31650375.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    35. Hemigland Cryoablation of Clinically Significant Prostate Cancer: Intermediate-Term Followup via Magnetic Resonance Imaging Guided Biopsy. J Urol. 2020 Nov; 204(5):941-949. Chuang R, Kinnaird A, Kwan L, Sisk A, Barsa D, Felker E, Delfin M, Marks L. PMID: 32985924.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    36. Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study. Eur Urol. 2021 04; 79(4):456-465. Salami SS, Tosoian JJ, Nallandhighal S, Jones TA, Brockman S, Elkhoury FF, Bazzi S, Plouffe KR, Siddiqui J, Liu CJ, Kunju LP, Morgan TM, Natarajan S, Boonstra PS, Sumida L, Tomlins SA, Udager AM, Sisk AE, Marks LS, Palapattu GS. PMID: 32631746; PMCID: PMC7779657.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    37. Risk of Prostate Cancer after a Negative Magnetic Resonance Imaging Guided Biopsy. J Urol. 2020 12; 204(6):1180-1186. Kinnaird A, Sharma V, Chuang R, Priester A, Tran E, Barsa DE, Delfin M, Kwan L, Sisk A, Felker E, Marks LS. PMID: 32614257.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    38. Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2. Abdom Radiol (NY). 2020 07; 45(7):2225-2234. Afshari Mirak S, Mohammadian Bajgiran A, Sung K, Asvadi NH, Markovic D, Felker ER, Lu D, Sisk A, Reiter RE, Raman SS. PMID: 31549211; PMCID: PMC10262973.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    39. Prostate Microstructure in Prostate Cancer Using 3-T MRI with Diffusion-Relaxation Correlation Spectrum Imaging: Validation with Whole-Mount Digital Histopathology. Radiology. 2020 08; 296(2):348-355. Zhang Z, Wu HH, Priester A, Magyar C, Afshari Mirak S, Shakeri S, Mohammadian Bajgiran A, Hosseiny M, Azadikhah A, Sung K, Reiter RE, Sisk AE, Raman S, Enzmann DR. PMID: 32515678.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    40. Influence of the Location and Zone of Tumor in Prostate Cancer Detection and Localization on 3-T Multiparametric MRI Based on PI-RADS Version 2. AJR Am J Roentgenol. 2020 05; 214(5):1101-1111. Wibulpolprasert P, Raman SS, Hsu W, Margolis DJA, Asvadi NH, Khoshnoodi P, Moshksar A, Tan N, Ahuja P, Maehara CK, Sisk A, Sayre J, Lu DSK, Reiter RE. PMID: 32130048; PMCID: PMC11288627.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    41. Acute interstitial nephritis and drug-induced systemic lupus erythematosus due to chlorthalidone and amiodarone: A case report. SAGE Open Med Case Rep. 2020; 8:2050313X20910029. Selamet U, Hanna RM, Sisk A, Abdelnour L, Ghobry L, Kurtz I. PMID: 32166031; PMCID: PMC7052449.
      View in: PubMed   Mentions:
    42. A case of renal and splenic LECT 2 amyloidosis: A recently recognized cause of renal and systemic amyloidosis. Saudi J Kidney Dis Transpl. 2020 Mar-Apr; 31(2):508-514. Shye M, Sisk A, Schulze C, Barsoum M, Mikhail M, Arman F, Rastogi A, Hanna RM. PMID: 32394925.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes. Proc Natl Acad Sci U S A. 2020 01 07; 117(1):563-572. Wang L, Smith BA, Balanis NG, Tsai BL, Nguyen K, Cheng MW, Obusan MB, Esedebe FN, Patel SJ, Zhang H, Clark PM, Sisk AE, Said JW, Huang J, Graeber TG, Witte ON, Chin AI, Park JW. PMID: 31871155; PMCID: PMC6955337.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    44. Long-Term Survival after Percutaneous Radiofrequency Ablation of Pathologically Proven Renal Cell Carcinoma in 100 Patients. J Vasc Interv Radiol. 2020 Jan; 31(1):15-24. Marshall HR, Shakeri S, Hosseiny M, Sisk A, Sayre J, Lu DS, Pantuck A, Raman S. PMID: 31767409.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    45. The California Telepathology Service: UCLA's Experience in Deploying a Regional Digital Pathology Subspecialty Consultation Network. J Pathol Inform. 2019; 10:31. Chong T, Palma-Diaz MF, Fisher C, Gui D, Ostrzega NL, Sempa G, Sisk AE, Valasek M, Wang BY, Zuckerman J, Khacherian C, Binder S, Wallace WD. PMID: 31620310; PMCID: PMC6788184.
      View in: PubMed   Mentions: 15  
    46. Magnetic Resonance Imaging-Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer. JAMA Netw Open. 2019 09 04; 2(9):e1911019. Jayadevan R, Felker ER, Kwan L, Barsa DE, Zhang H, Sisk AE, Delfin M, Marks LS. PMID: 31509206; PMCID: PMC6739900.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    47. Comparison of Targeted vs Systematic Prostate Biopsy in Men Who Are Biopsy Naive: The Prospective Assessment of Image Registration in the Diagnosis of Prostate Cancer (PAIREDCAP) Study. JAMA Surg. 2019 09 01; 154(9):811-818. Elkhoury FF, Felker ER, Kwan L, Sisk AE, Delfin M, Natarajan S, Marks LS. PMID: 31188412; PMCID: PMC6563598.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    48. Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI. AJR Am J Roentgenol. 2019 09; 213(3):W134-W142. Bajgiran AM, Mirak SA, Sung K, Sisk AE, Reiter RE, Raman SS. PMID: 31216201.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    49. The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas. Abdom Radiol (NY). 2019 06; 44(6):2308-2315. Shakeri S, Afshari Mirak S, Mohammadian Bajgiran A, Pantuck A, Sisk A, Ahuja P, Lu DS, Raman SS. PMID: 30847565.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    50. Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection. Cancer. 2019 09 01; 125(17):2955-2964. Johnson DC, Yang JJ, Kwan L, Barsa DE, Mirak SA, Pooli A, Sadun T, Jayadevan R, Zhou S, Priester AM, Natarajan S, Bajgiran AM, Shakeri S, Sisk A, Felker ER, Raman SS, Marks LS, Reiter RE. PMID: 31042322; PMCID: PMC7368458.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    51. Cancer-Associated AA Amyloidosis Presenting as Crescentic Glomerulonephritis. Kidney Int Rep. 2019 Jun; 4(6):882-887. Zuckerman JE, Peng F, Karl BE, Schulze CE, Sisk A. PMID: 31194182; PMCID: PMC6551570.
      View in: PubMed   Mentions: 6  
    52. Virtual histological staining of unlabelled tissue-autofluorescence images via deep learning. Nat Biomed Eng. 2019 06; 3(6):466-477. Rivenson Y, Wang H, Wei Z, de Haan K, Zhang Y, Wu Y, Günaydin H, Zuckerman JE, Chong T, Sisk AE, Westbrook LM, Wallace WD, Ozcan A. PMID: 31142829.
      View in: PubMed   Mentions: 192     Fields:    Translation:Humans
    53. Three Tesla Multiparametric Magnetic Resonance Imaging: Comparison of Performance with and without Endorectal Coil for Prostate Cancer Detection, PI-RADS™ version 2 Category and Staging with Whole Mount Histopathology Correlation. J Urol. 2019 03; 201(3):496-502. Mirak SA, Shakeri S, Bajgiran AM, Felker ER, Sung KH, Asvadi NH, Khoshnoodi P, Markovic D, Ponzini D, Ahuja P, Sisk A, Reiter RE, Lu D, Raman SS. PMID: 30273608.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    54. Characteristics of missed prostate cancer lesions on 3T multiparametric-MRI in 518 patients: based on PI-RADSv2 and using whole-mount histopathology reference. Abdom Radiol (NY). 2019 03; 44(3):1052-1061. Mohammadian Bajgiran A, Afshari Mirak S, Shakeri S, Felker ER, Ponzini D, Ahuja P, Sisk AE, Lu DS, Raman SS. PMID: 30460528.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    55. Cancer core length from targeted biopsy: an index of prostate cancer volume and pathological stage. BJU Int. 2019 08; 124(2):275-281. Simopoulos DN, Sisk AE, Priester A, Felker ER, Kwan L, Delfin MK, Reiter RE, Marks LS. PMID: 30694605; PMCID: PMC6641990.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    56. Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer. Eur Urol. 2019 07; 76(1):18-23. Houlahan KE, Salmasi A, Sadun TY, Pooli A, Felker ER, Livingstone J, Huang V, Raman SS, Ahuja P, Sisk AE, Boutros PC, Reiter RE. PMID: 30685078; PMCID: PMC10228592.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    57. Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging. Eur Urol. 2019 05; 75(5):712-720. Johnson DC, Raman SS, Mirak SA, Kwan L, Bajgiran AM, Hsu W, Maehara CK, Ahuja P, Faiena I, Pooli A, Salmasi A, Sisk A, Felker ER, Lu DSK, Reiter RE. PMID: 30509763.
      View in: PubMed   Mentions: 108     Fields:    Translation:Humans
    58. Clear cell renal cell carcinoma: identifying PTEN expression on multiphasic MDCT. Abdom Radiol (NY). 2018 12; 43(12):3410-3417. Young JR, Coy H, Kim HJ, Douek M, Sisk A, Pantuck AJ, Raman SS. PMID: 29946925.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. 3T multiparametric MR imaging, PIRADSv2-based detection of index prostate cancer lesions in the transition zone and the peripheral zone using whole mount histopathology as reference standard. Abdom Radiol (NY). 2018 11; 43(11):3117-3124. Asvadi NH, Afshari Mirak S, Mohammadian Bajgiran A, Khoshnoodi P, Wibulpolprasert P, Margolis D, Sisk A, Reiter RE, Raman SS. PMID: 29725743; PMCID: PMC6922085.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    60. Association of the Gross Appearance of Intratumoral Vascularity at MDCT With the Carbonic Anhydrase IX Score in Clear Cell Renal Cell Carcinoma. AJR Am J Roentgenol. 2018 12; 211(6):1254-1258. Young JR, Coy H, Kim HJ, Douek M, Sisk A, Pantuck AJ, Raman SS. PMID: 30300009.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    61. Utility of multiphasic multidetector computed tomography in discriminating between clear cell renal cell carcinomas with high and low carbonic anhydrase-IX expression. Abdom Radiol (NY). 2018 10; 43(10):2734-2742. Young JR, Coy H, Kim HJ, Douek M, Sisk A, Belldegrun A, Pantuck AJ, Raman SS. PMID: 29520426.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    62. PD 1 checkpoint inhibition in solid organ transplants: 2 sides of a coin - case report. BMC Nephrol. 2018 08 20; 19(1):210. Goldman JW, Abdalla B, Mendenhall MA, Sisk A, Hunt J, Danovitch GM, Lum EL. PMID: 30126374; PMCID: PMC6102916.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    63. A system using patient-specific 3D-printed molds to spatially align in vivo MRI with ex vivo MRI and whole-mount histopathology for prostate cancer research. J Magn Reson Imaging. 2019 01; 49(1):270-279. Wu HH, Priester A, Khoshnoodi P, Zhang Z, Shakeri S, Afshari Mirak S, Asvadi NH, Ahuja P, Sung K, Natarajan S, Sisk A, Reiter R, Raman S, Enzmann D. PMID: 30069968.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    64. Radical prostatectomy then and now: Surgical overtreatment of prostate cancer is declining from 2009 to 2016 at a tertiary referral center. Urol Oncol. 2018 09; 36(9):401.e19-401.e25. Salmasi A, Faiena I, Wu J, Sisk AE, Sachveda A, Vandel JJ, Chamie K, Marks LS, Reiter RE. PMID: 30064933.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    65. Registration Accuracy of Patient-Specific, Three-Dimensional-Printed Prostate Molds for Correlating Pathology With Magnetic Resonance Imaging. IEEE Trans Biomed Eng. 2019 01; 66(1):14-22. Priester A, Wu H, Khoshnoodi P, Schneider D, Zhang Z, Asvadi NH, Sisk A, Raman S, Reiter R, Grundfest W, Marks LS, Natarajan S. PMID: 29993431; PMCID: PMC6344233.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    66. A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy. J Urol. 2018 09; 200(3):564-572. Salmasi A, Said J, Shindel AW, Khoshnoodi P, Felker ER, Sisk AE, Grogan T, McCullough D, Bennett J, Bailey H, Lawrence HJ, Elashoff DA, Marks LS, Raman SS, Febbo PG, Reiter RE. PMID: 29524506.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    67. Targeted Prostate Biopsy Using 68Gallium PSMA-PET/CT for Image Guidance. Urol Case Rep. 2017 Sep; 14:11-14. Simopoulos DN, Natarajan S, Jones TA, Fendler WP, Sisk AE, Marks LS. PMID: 28607878; PMCID: PMC5458645.
      View in: PubMed   Mentions: 12  
    68. Adrenal Teratoma: a Case Series and Review of the Literature. Endocr Pathol. 2017 Jun; 28(2):152-158. Kuo EJ, Sisk AE, Yang Z, Huang J, Yeh MW, Livhits MJ. PMID: 28091891.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    69. Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance. J Urol. 2017 10; 198(4):839-847. Natarajan S, Jones TA, Priester AM, Geoghegan R, Lieu P, Delfin M, Felker E, Margolis DJA, Sisk A, Pantuck A, Grundfest W, Marks LS. PMID: 28396184.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    70. Novel association of familial testicular germ cell tumor and autosomal dominant polycystic kidney disease with PKD1 mutation. Pediatr Blood Cancer. 2017 01; 64(1):100-102. Truscott L, Gell J, Chang VY, Lee H, Strom SP, Pillai R, Sisk A, Martinez-Agosto JA, Anderson M, Federman N. PMID: 27577987; PMCID: PMC5937546.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    71. alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol. 2000 Aug; 157(2):401-10. Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M, Wong J, Takenouchi T, Hashimoto M, Masliah E. PMID: 10934145; PMCID: PMC1850140.
      View in: PubMed   Mentions: 275     Fields:    Translation:AnimalsCells
    Anthony's Networks
    Concepts (207)
    Derived automatically from this person's publications.
    _
    Co-Authors (78)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _